Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

83%(5 trials)

Phase Distribution

Ph phase_4

30%

Ph phase_3

40%

Ph phase_1

10%

Ph phase_2

10%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

1(11.1%)

Phase 2Efficacy & side effects

1(11.1%)

Phase 3Large-scale testing

4(44.4%)

Phase 4Post-market surveillance

3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Terminated(3)

Other(1)

Detailed Status

Completed6

Withdrawn3

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (11.1%)

Phase 21 (11.1%)

Phase 34 (44.4%)

Phase 43 (33.3%)

Trials by Status

unknown110%

withdrawn330%

completed660%

Recent Activity

0 active trials

Showing 5 of 10

withdrawnphase_4

Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery

NCT04246541

completedphase_3

Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery

NCT04246554

View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials

NCT02703610Phase 4

Randomized Trial of Two Analgesics in Elderly ED Patients

Withdrawn

NCT01810458

Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)

Completed

NCT04939987Phase 2

Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy

Withdrawn

NCT04246541Phase 3

Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery

Completed

NCT04246554Phase 3

Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery

Completed

NCT02480114Phase 3

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Completed

NCT04112550Phase 1

Clinical Effectiveness of Pre-operative Methadone in Single Level Lateral Transpsoas Interbody Fusions

Unknown

NCT03529331Phase 4

A Study Comparing Recurrent Use of MSIR, Percocet, and Vicodin at Discharge From the ED

Withdrawn

NCT02455518Phase 4

Comparative Efficacy of 4 Oral Analgesics

Completed

NCT01270659Phase 3

Safety and Efficacy Study of Fentanyl Buccal Tablet Use in the Emergency Department for Isolated Extremity Injury

Completed

All 10 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 10